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The eﬀ ect of HIV and the modifying eﬀ ect of antiretroviral 
therapy on body-mass index and blood pressure levels in 
rural South Africa
Andrea B Feigl, Frank Tanser, Till W Bärnighausen
Abstract
Background The trajectory of body-mass index (BMI) in long-term HIV patients on antiretroviral therapy (ART) 
compared with the non-HIV population has been poorly studied.
Methods Methods In 2003 and 2010, height, weight, and blood pressure measurements were recorded in a subset 
(n=505) of the population in KwaZulu-Natal, South Africa—a region with a very high prevalence of HIV (30%) and 
intensive ART rollout since 2004. Diﬀ erence analysis was used to study change in BMI and blood pressure over time 
in HIV-negative patients, HIV-positive patients who had been on ART for 0–<2 years (HIV+ART0–<2 years; n=62), HIV 
patients who had been on ART for 2–5 years (HIV+ART2–5 years; n=44), and HIV-positive patients who were not on ART 
(HIV+ART–; n=52). Multinomial logistic regression models were used to assess change in the risk of obesity and 
hypertension.
Findings The HIV-negative and HIV-positive groups were both overweight at baseline (mean BMI 29·5, 
95% CI 28·8–30·3; and 27·5, 25·9–29–3, respectively). The HIV-negative group was obese in 2010 (mean BMI >30); all 
other groups remained in the overweight range (25< BMI <30). The diﬀ erence in change in BMI between the 
HIV-negative and the HIV-positive ART0–<2 years group was –5·21 (95% CI –7·53 to –2·89; p=0·001). This diﬀ erence 
in change in BMI was attenuated by increased ART use, with a diﬀ erence in BMI change between the HIV- and the 
HIV+ART2–5 group of –1·07 (95% CI –2·5 to 0·361; p=0·086), suggesting a U-shaped association of BMI with ART use. 
The diﬀ erence in change in BMI between the HIV+ART– and the HIV+ART0–<2 years group was –4·14 (95% CI –6·76 
to –1·53; p=0·002). The HIV+ART– group had the highest average systolic blood pressure in 2003. Compared with the 
HIV– group, the overall systolic blood pressure in the HIV+ART– group signiﬁ cantly declined by –7·55 mm Hg (95% 
CI –13·2 to –1.90; p=0·009). The eﬀ ect of the dose of ART on systolic blood pressure change was not signiﬁ cant 
(p=0·853).
Interpretation Short-term ART exposure (0–<2 years) was associated with a slight decline in BMI compared with all 
other populations, because patients are selected into ART on the basis of having advanced HIV disease. Long-term 
ART exposure (2–5 years) led to a return to a highly overweight BMI and an increased chance of being obese than 
normal weight by 2010.
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